期刊文献+

老年心力衰竭患者血胆红素水平的变化 被引量:2

下载PDF
导出
摘要 研究发现,血红素氧化酶/一氧化碳-胆红素系统在临床上具有很重要的意义。血红素氧化酶把血红素分解成胆绿素和一氧化碳,那么,胆绿素在还原酶的作用下马上转化为胆红素〔1,2〕。过去一般都把血胆红素水平作为诊断肝胆系统疾病的指标。近年来,血红素氧化酶/一氧化碳-胆红素系统在心脏中所起到的保护作用倍受关注。而且,经过动物实验也证明了血红素氧化酶-1是一种热休克蛋白,
作者 胡勇军
机构地区 湖南省人民医院
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第14期3438-3439,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献5

二级参考文献41

  • 1BREIMER L H,WANNAMETHEE G,EBRAHIM S,et al.Serum bilirubin and risk of ischemic heart disease in middle-aged British men[J].Clin Chem,1995,41(10):1504-1508.
  • 2MAYER M.Association of serum bilirubin concentration with risk of coronary artery disease[J].Clin Chem,2000,46(11):1723-1727.
  • 3LIN J P,LUPPLES L A,WILSON P W.Evidence for a gene influencing serum bilirubin on chromosome 2q telomere: a genomeuide scan in the Framingham study [J].Am J Hum Genet,2003,72(4):1029-1034.
  • 4TAKAHASHI H,HARA K.Cardiovascular diseases and oxidative stress[J].Rinsho Byori,2003,51(2):133-139.
  • 5KAWAMURA K,ISHIKAWA K,WADA Y.Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction[J].Arterioscler Thromb Vasc Biol,2005,25(1):155-160.
  • 6SULLIVAN J L.Iron and the sex difference in heart disease risk[J].Lancet,1981,1(8233):1293-1294.
  • 7SALONEN J T,NYYSSONEN K,KORPECA H,et al.High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men [J].Circulation,1992,86(3):803-810.
  • 8KRAML P,POTOCKOVA J,KOPRIVOVA H,et al.Ferritin、 oxidative stress and coronary atherosclerosis[J].Vnitr Lek,2004,50(3):197-202.
  • 9HOLVOET P,COLLEN D.Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis[J].Atherosclerosis,1998,137(suppl):s33-s38.
  • 10VLASAKOVA Z,PELIKANOVA T,KAZADOVA L,et al.Serum ferritin、 LDL oxidation and risk factors for atherogenesis in healthy offspring of hypertensive patients[J].Vnitr Lek,2002,48(2):105-111.

共引文献23

同被引文献19

  • 1鲁祖建,易剑明.冠心病患者血清胆红素与血尿酸及血脂水平关系的研究[J].中国医师杂志,2005,7(4):555-556. 被引量:10
  • 2刘振兵,刘晓方.慢性心力衰竭患者血尿酸水平和肾功能变化的研究[J].宁夏医学杂志,2006,28(8):574-575. 被引量:9
  • 3Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: Data from the Candesartan in Heart Failure:Assessment of Reduction in Mortali- ty and Morbidity(CHARM) program [J]. Eur J Heart Fail,2009, 11(2) :170 - 177.
  • 4Wu XL,Zhu R,Jiang H,etal. Different treatment interventions af feet plasma NT - ProBNP levels and early exercise tolerance in pa tients with acute ST - segment elevation myocardial infarction[J]. Postgrad Med,2012,124(2) :58 - 63.
  • 5无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3677
  • 6Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study [ J]. Ann Intern Med, 1999,131 ( 1 ) :7-13.
  • 7Fang J, Aldemran MH." Serum uric acid and cardiovascular mortal- ity the NHANES I epidemiologic follow-up study, 1971-1992. Na- tional Health and Nutrition Examination Survey[J]. JAMA,2000, 283 ( 18 ) :2404-2410.
  • 8Schwertner HA, Jackson WG, Tolan G. Association of low serum- concentration of bilirubin with increased risk of coronary artery dis- ease[ J]. Clin Chem,1994,40( 1 ) : 18-23.
  • 9Wang X, Wang Y, Kim HP, et al. Carbon monoxide protects a- gainst hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation [ J ]. J Biol Chem, 2007,282 (3) :1718-1726.
  • 10Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure Assessment of Reduction in Mortali-ty and Morbidity (CHARM) program [ J ]. Eur J Heart Fai| ,2009, 11 (2) :170-177.

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部